The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.2 pts more than Nifty Microcap 250 and 0.8 pts more than its Retailing peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Catalyst Trusteeship Limited, acting as Debenture Trustee for debenture holders, has disclosed a release of 41,71,970 pledged equity shares (3.48% of total share capital) of Medplus Health Services on December 24, 2025. Prior to the release, Catalyst Trusteeship held 1,07,98,429 shares (9.01%) as encumbrance on behalf of debenture holders. After the release, its encumbered holding stands at 66,26,459 shares (5.53%). Catalyst Trusteeship is not a promoter or part of the promoter group — it acts solely in the capacity of a Debenture Trustee.
Reduction in encumbered (pledged) shares by ~3.48% is mildly positive, as it lowers the pledge overhang on the stock. However, since Catalyst Trusteeship is not a promoter, this is a routine debenture-related disclosure with limited direct impact on promoter control or share price.